Study to Investigate Comparative Efficacy, Safety and Immunogenicity Between AVT16 and Entyvio

NCT06570772 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

301

Enrollment

INDUSTRY

Sponsor class

Stopped The study has been terminated based on Sponsor decision. This decision is not related to any safety concerns associated with the investigational products. It is related to the fact that study will be not required for product dossier submission.

Conditions

Ulcerative Colitis

Interventions

BIOLOGICAL: AVT16
BIOLOGICAL: Vedolizumab

Sponsor

Alvotech Swiss AG